On December 30, 2013, the U.S. Food and Drug Administration (FDA) declined to approve a promising drug, Lemtrada, to aid individuals who are afflicted by multiple sclerosis (MS), specifically it was “to be used for relapsing-remitting MS.” According to Kathleen Doheny on WebMD.com the reason cited by the FDA for disapproving Lemtrada for MS patients […]